低血清Mitsugumin 53水平与血液透析患者血管化的风险之间的关联
Wenwen Ren1, Conghui Liu1, Ying Yan1
1Department of Nephrology, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China.
概括
低血清Mitsugumin 53 (MG53) 水平与血液透析患者腹腔大动脉化 (AAC) 风险增加有关. 这一发现突出了MG53的MG53.
科学领域:
- 生物化学和分子生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管医学 心血管医学
背景情况:
- 三重53 (MG53) 以其对脏和心血管疾病的保护作用而闻名.
- 根据MG53的保护作用,特别是预防血管化,确切的机制仍然在很大程度上未被阐明.
- 血管化是接受血液透析 (HD) 的患者的重大并发症.
研究的目的:
- 在接受血液透析 (HD) 的患者中,研究血清MG53水平与腹腔大动脉化 (AAC) 之间的潜在关联.
- 为了确定HD患者群体中AAC的风险因素.
主要方法:
- 一个研究队列包括263名HD患者和65名健康对照.
- 血清MG53水平使用酶相关免疫吸收试验 (ELISA) 量化.
- 腹腔大动脉化得分 (ACCs) 通过腹部侧侧放射测定.
主要成果:
- 与健康个体相比,HD患者的血清MG53水平显著降低.
- 患有AAC的HD患者的血清MG53水平明显低于没有AAC的患者.
- 血清MG53较低,年龄较大,透析年限较长,血清TCO2较高和血清含量较高被确定为AAC的独立危险因素.
结论:
- 这项研究确立了血清MG53水平降低与HD患者AAC风险增加之间的新相关性.
- 在疾病发病患者中,AAC的独立风险因素包括年龄较大,长时间透析,代谢性酸性疾病和血清含量升高.
相关概念视频
Skeleton and Calcium Homeostasis
4.3K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.3K
Factors Affecting Renal Clearance: Renal Impairment
36
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
36
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
38
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38


